273 related articles for article (PubMed ID: 22850059)
41. [H1N1 influenza - pandemic, 2009].
Osztovits J; Balázs C; Fehér J
Orv Hetil; 2009 Dec; 150(50):2265-73. PubMed ID: 19951858
[TBL] [Abstract][Full Text] [Related]
42. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
[TBL] [Abstract][Full Text] [Related]
43. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Chawla R; Sharma RK; Bhardwaj JR
Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
[TBL] [Abstract][Full Text] [Related]
44. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
45. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century.
Chang LY; Shih SR; Shao PL; Huang DT; Huang LM
J Formos Med Assoc; 2009 Jul; 108(7):526-32. PubMed ID: 19586825
[TBL] [Abstract][Full Text] [Related]
46. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
47. Vero/CHOK1, a novel mixture of cell lines that is optimal for the rescue of influenza A vaccine seeds.
Medina J; Guillot V; Totain E; Rouleau M; Sodoyer R; Moste C; Legastelois I
J Virol Methods; 2014 Feb; 196():25-31. PubMed ID: 24161812
[TBL] [Abstract][Full Text] [Related]
48. Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.
Michaelis M; Doerr HW; Cinatl J
Med Microbiol Immunol; 2009 Aug; 198(3):175-83. PubMed ID: 19543913
[TBL] [Abstract][Full Text] [Related]
49. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
[TBL] [Abstract][Full Text] [Related]
50. Government orders supplies of swine flu vaccine to cope with pandemic.
Doherty L
Paediatr Nurs; 2009 Sep; 21(7):4. PubMed ID: 19791658
[No Abstract] [Full Text] [Related]
51. Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response.
Meunier I; Morisseau O; Garneau É; Marois I; Cloutier A; Richter MV
PLoS One; 2015; 10(9):e0138055. PubMed ID: 26381265
[TBL] [Abstract][Full Text] [Related]
52. Towards a sane and rational approach to management of Influenza H1N1 2009.
Gallaher WR
Virol J; 2009 May; 6():51. PubMed ID: 19422701
[TBL] [Abstract][Full Text] [Related]
53. [Influenza A (H1N1). fear of a pandemic].
Gotera J; Valero N
Invest Clin; 2009 Sep; 50(3):279-81. PubMed ID: 19961050
[TBL] [Abstract][Full Text] [Related]
54. Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells.
Frensing T; Kupke SY; Bachmann M; Fritzsche S; Gallo-Ramirez LE; Reichl U
Appl Microbiol Biotechnol; 2016 Aug; 100(16):7181-92. PubMed ID: 27129532
[TBL] [Abstract][Full Text] [Related]
55. Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.
Zhou J; Yang F; Yang J; Ma L; Cun Y; Song S; Liao G
Hum Vaccin Immunother; 2017 Jan; 13(1):111-116. PubMed ID: 27648636
[TBL] [Abstract][Full Text] [Related]
56. H1N1 Swine Flu: The 2010 Perspective--A New York Academy of Sciences Meeting.
Minieri Arroyo J
IDrugs; 2010 Jul; 13(7):448-52. PubMed ID: 20582868
[TBL] [Abstract][Full Text] [Related]
57. Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.
Milián E; Julien T; Biaggio R; Venereo-Sanchez A; Montes J; Manceur AP; Ansorge S; Petiot E; Rosa-Calatrava M; Kamen A
Vaccine; 2017 Jun; 35(26):3423-3430. PubMed ID: 28495315
[TBL] [Abstract][Full Text] [Related]
58. The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making.
Lee BY; Wiringa AE
Hum Vaccin; 2011 Jan; 7(1):115-9. PubMed ID: 21263227
[TBL] [Abstract][Full Text] [Related]
59. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.
O'Neill E; Donis RO
Curr Top Microbiol Immunol; 2009; 333():83-108. PubMed ID: 19768401
[TBL] [Abstract][Full Text] [Related]
60. Influenza vaccines: a main problem in control of pandemics.
Ghendon Y
Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
